Klaria Pharma Holding AB (publ.) (STO:KLAR)
Sweden · Delayed Price · Currency is SEK 0.9400
+0.0020 (0.21%)
Jan 21, 2026, 2:18 PM CET
STO:KLAR Revenue
Klaria Pharma Holding AB (publ.) had revenue of 10.05M SEK in the twelve months ending September 30, 2025, up 303.82% year-over-year. In the year 2024, Klaria Pharma Holding AB (publ.) had annual revenue of 2.25M, down -73.41%.
Revenue (ttm)
10.05M
Revenue Growth
+303.82%
P/S Ratio
22.96
Revenue / Employee
2.51M
Employees
4
Market Cap
230.73M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.25M | -6.21M | -73.41% |
| Dec 31, 2023 | 8.45M | 2.59M | 44.07% |
| Dec 31, 2022 | 5.87M | -244.00K | -3.99% |
| Dec 31, 2021 | 6.11M | -1.11M | -15.35% |
| Dec 31, 2020 | 7.22M | -4.35M | -37.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Orexo AB | 543.50M |
| EQL Pharma AB | 399.07M |
| Enzymatica AB | 52.73M |
| Cinclus Pharma Holding AB | 48.42M |
| Cereno Scientific AB | 46.66M |
| Nanexa AB | 31.92M |
| Newbury Pharmaceuticals AB | 31.57M |
| Moberg Pharma AB | 12.50M |